世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3956
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫調節剤、免疫抑制剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多発性硬化症治療の市場動向
・企業の競争状況、市場シェア
・多発性硬化症治療の種類別市場規模（免疫調節剤、免疫抑制剤）
・多発性硬化症治療の用途別市場規模（病院、クリニック、その他）
・多発性硬化症治療の北米市場規模2016-2027（アメリカ、カナダ）
・多発性硬化症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性硬化症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性硬化症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性硬化症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Teva Pharmaceutical Industries、Bayer、Biogen Idec、Pfizer、Novartis）
・結論

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.

Market Analysis and Insights: Global Multiple Sclerosis Treatment Market
The global Multiple Sclerosis Treatment market size is projected to reach US$ 19600 million by 2026, from US$ 17030 million in 2019, at a CAGR of 2.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Sclerosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Sclerosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Sclerosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Sclerosis Treatment market.

Global Multiple Sclerosis Treatment Scope and Market Size
Multiple Sclerosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunomodulators
Immunosuppressant

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva Pharmaceutical Industries
Bayer
Biogen Idec
Pfizer
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunomodulators
1.2.3 Immunosuppressant
1.3 Market by Application
1.3.1 Global Multiple Sclerosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Sclerosis Treatment Market Perspective (2016-2027)
2.2 Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Multiple Sclerosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Sclerosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Sclerosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Sclerosis Treatment Industry Dynamic
2.3.1 Multiple Sclerosis Treatment Market Trends
2.3.2 Multiple Sclerosis Treatment Market Drivers
2.3.3 Multiple Sclerosis Treatment Market Challenges
2.3.4 Multiple Sclerosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Treatment Players by Revenue
3.1.1 Global Top Multiple Sclerosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Sclerosis Treatment Revenue
3.4 Global Multiple Sclerosis Treatment Market Concentration Ratio
3.4.1 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Treatment Revenue in 2020
3.5 Multiple Sclerosis Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Sclerosis Treatment Product Solution and Service
3.7 Date of Enter into Multiple Sclerosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Sclerosis Treatment Breakdown Data by Type
4.1 Global Multiple Sclerosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2022-2027)

5 Multiple Sclerosis Treatment Breakdown Data by Application
5.1 Global Multiple Sclerosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Sclerosis Treatment Market Size (2016-2027)
6.2 North America Multiple Sclerosis Treatment Market Size by Type
6.2.1 North America Multiple Sclerosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Multiple Sclerosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Multiple Sclerosis Treatment Market Size by Type (2016-2027)
6.3 North America Multiple Sclerosis Treatment Market Size by Application
6.3.1 North America Multiple Sclerosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Multiple Sclerosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Multiple Sclerosis Treatment Market Size by Application (2016-2027)
6.4 North America Multiple Sclerosis Treatment Market Size by Country
6.4.1 North America Multiple Sclerosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Multiple Sclerosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Multiple Sclerosis Treatment Market Size (2016-2027)
7.2 Europe Multiple Sclerosis Treatment Market Size by Type
7.2.1 Europe Multiple Sclerosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multiple Sclerosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multiple Sclerosis Treatment Market Size by Type (2016-2027)
7.3 Europe Multiple Sclerosis Treatment Market Size by Application
7.3.1 Europe Multiple Sclerosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multiple Sclerosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multiple Sclerosis Treatment Market Size by Application (2016-2027)
7.4 Europe Multiple Sclerosis Treatment Market Size by Country
7.4.1 Europe Multiple Sclerosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multiple Sclerosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Sclerosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multiple Sclerosis Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Sclerosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Sclerosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Sclerosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Sclerosis Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Sclerosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Sclerosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Sclerosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Sclerosis Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Sclerosis Treatment Market Size (2016-2027)
9.2 Latin America Multiple Sclerosis Treatment Market Size by Type
9.2.1 Latin America Multiple Sclerosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Sclerosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Sclerosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Multiple Sclerosis Treatment Market Size by Application
9.3.1 Latin America Multiple Sclerosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Sclerosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Sclerosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Multiple Sclerosis Treatment Market Size by Country
9.4.1 Latin America Multiple Sclerosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Sclerosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Sclerosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Sclerosis Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Sclerosis Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Details
11.1.2 Teva Pharmaceutical Industries Business Overview
11.1.3 Teva Pharmaceutical Industries Multiple Sclerosis Treatment Introduction
11.1.4 Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2016-2021)
11.1.5 Teva Pharmaceutical Industries Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Multiple Sclerosis Treatment Introduction
11.2.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Biogen Idec
11.3.1 Biogen Idec Company Details
11.3.2 Biogen Idec Business Overview
11.3.3 Biogen Idec Multiple Sclerosis Treatment Introduction
11.3.4 Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2016-2021)
11.3.5 Biogen Idec Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Multiple Sclerosis Treatment Introduction
11.4.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Multiple Sclerosis Treatment Introduction
11.5.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2016-2021)
11.5.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunomodulators
Table 3. Key Players of Immunosuppressant
Table 4. Global Multiple Sclerosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Multiple Sclerosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multiple Sclerosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Multiple Sclerosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Multiple Sclerosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Multiple Sclerosis Treatment Market Share by Regions (2022-2027)
Table 10. Multiple Sclerosis Treatment Market Trends
Table 11. Multiple Sclerosis Treatment Market Drivers
Table 12. Multiple Sclerosis Treatment Market Challenges
Table 13. Multiple Sclerosis Treatment Market Restraints
Table 14. Global Multiple Sclerosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Multiple Sclerosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Treatment as of 2020)
Table 17. Ranking of Global Top Multiple Sclerosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Multiple Sclerosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Multiple Sclerosis Treatment Product Solution and Service
Table 21. Date of Enter into Multiple Sclerosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Multiple Sclerosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Multiple Sclerosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Multiple Sclerosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Multiple Sclerosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Multiple Sclerosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Multiple Sclerosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Multiple Sclerosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Multiple Sclerosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Teva Pharmaceutical Industries Company Details
Table 62. Teva Pharmaceutical Industries Business Overview
Table 63. Teva Pharmaceutical Industries Multiple Sclerosis Treatment Product
Table 64. Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 65. Teva Pharmaceutical Industries Recent Development
Table 66. Bayer Company Details
Table 67. Bayer Business Overview
Table 68. Bayer Multiple Sclerosis Treatment Product
Table 69. Bayer Revenue in Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 70. Bayer Recent Development
Table 71. Biogen Idec Company Details
Table 72. Biogen Idec Business Overview
Table 73. Biogen Idec Multiple Sclerosis Treatment Product
Table 74. Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Biogen Idec Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Multiple Sclerosis Treatment Product
Table 79. Pfizer Revenue in Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Multiple Sclerosis Treatment Product
Table 84. Novartis Revenue in Multiple Sclerosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunomodulators Features
Figure 3. Immunosuppressant Features
Figure 4. Global Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Multiple Sclerosis Treatment Report Years Considered
Figure 9. Global Multiple Sclerosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Multiple Sclerosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Multiple Sclerosis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Multiple Sclerosis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Multiple Sclerosis Treatment Market Share by Players in 2020
Figure 14. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Multiple Sclerosis Treatment Revenue in 2020
Figure 16. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 20. North America Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 21. North America Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 22. United States Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Multiple Sclerosis Treatment Market Share by Region (2016-2027)
Figure 38. China Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Multiple Sclerosis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Multiple Sclerosis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Multiple Sclerosis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Multiple Sclerosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Multiple Sclerosis Treatment Business (2016-2021)
Figure 58. Bayer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2016-2021)
Figure 59. Biogen Idec Revenue Growth Rate in Multiple Sclerosis Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Multiple Sclerosis Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Multiple Sclerosis Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Sclerosis Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3955 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ベータインターフェロン、コルチコステロイド、モノクローナル抗体、抗腫瘍剤、その他）、用途別市場規模（病院薬局、小売薬局、eコマース）、主...

世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年）

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Progressive Relapsing Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4818 2021年4月 99Pages
QYResearch社発行の本調査資料では、進行性再発性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（COG-133、GZ-402668、イネビリズマブ、VCE-0032、その他）、用途別市場規模（診療所、病院、その他）、主要...

世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年）

Global Primary Progressive Multiple Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4790 2021年4月 94Pages
QYResearch社発行の本調査資料では、一次進行性多発性硬化症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ApE、ビオチン、GZ-402668、イブジラスト、イデベノン、ラキニモドナトリウム、その他）、用途別市場規模（病院、診療所、...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027
QYR2104Z5441 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0301 2021年4月 90Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ルーゲーリック病）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、幹細胞治療）、用途別市場規模（病院、診断センター、クリニック、小売薬局）、主要地域別市場規模（北米、...

世界の筋萎縮性側索硬化症（ルーゲーリック病）治療市場規模・現状・予測（2021年-2027年）

世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0303 2021年4月 90Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、理学療法、言語療法、その他）、用途別市場規模（病院、専門センター、研究センター、その他）、主要地域別市場規模（...

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3954 2021年4月 91Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別市場規模（病...

世界の進行性再発性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Progressive Relapsing Multiple Sclerosis Treatment Market The global Progressive Relapsing Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standar…
世界の一次進行性多発性硬化症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Primary Progressive Multiple Sclerosis Treatment Market The global Primary Progressive Multiple Sclerosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard ac…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
世界の多発性硬化症治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the d…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…